Sarepta Therapeutics SRPT
NASDAQ SRPT
$17.50 -0.07 (-0.40%)
At close: Oct 2, 2026 · 4:00 PM EDT

Sarepta Therapeutics (SRPT) Cost of Revenue (2017 - 2026)

Updated

Sarepta Therapeutics' Cost of Revenue was $149.39 million in Q2 2026, down 2.1% from $152.56 million a year earlier but up 37.3% from the prior quarter.

Analysis

Sarepta Therapeutics (SRPT) Cost of Revenue (2017 - 2026) Analysis & Trends

On a trailing twelve-month basis, Sarepta Therapeutics' Cost of Revenue was $807.64 million through Jun 30, 2026, up 57.1% year-over-year; for FY2025, it was $839.61 million, up 163.1% from FY2024.

  • Cost of Revenue has now increased for eight consecutive years, with a five-year compound annual growth rate of 67.7% (FY2020 to FY2025).
  • In earlier years, Cost of Revenue was $319.1 million in FY2024 (+112.2%), $150.34 million in FY2023 (+7.4%), $139.99 million in FY2022 (+44.2%) and $97.05 million in FY2021 (+53.1%).
  • Quarterly Cost of Revenue has moved between $23.44 million (Q3 2021) and $398.71 million (Q4 2025) over five years.
  • Compared with a year earlier, Cost of Revenue was higher in six of the last eight quarters, with growth averaging 125.6%.
  • The best year-over-year quarter for Cost of Revenue over five years was Q2 2025 (growth of 242.5%); the worst was Q1 2026 (a decline of 20.9%).
  • Per Business Quant data, SRPT's Cost of Revenue in the three quarters before Q2 2026 was $108.77 million (Q1 2026), $398.71 million (Q4 2025) and $150.78 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 8.05 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.29 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.52 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.58 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.09 Bn
10 Sarepta Therapeutics 1.85 Bn -1.38 Bn 251.87 Mn 149.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 149.39 Mn
Mar 31, 2026 108.77 Mn
Dec 31, 2025 398.71 Mn
Sep 30, 2025 150.78 Mn
Jun 30, 2025 152.56 Mn
Mar 31, 2025 137.56 Mn
Dec 31, 2024 132.30 Mn
Sep 30, 2024 91.69 Mn
Jun 30, 2024 44.55 Mn
Mar 31, 2024 50.56 Mn
Dec 31, 2023 44.18 Mn
Sep 30, 2023 37.03 Mn
Jun 30, 2023 34.12 Mn
Mar 31, 2023 35.02 Mn
Dec 31, 2022 30.80 Mn
Sep 30, 2022 39.95 Mn
Jun 30, 2022 37.80 Mn
Mar 31, 2022 31.44 Mn
Dec 31, 2021 31.74 Mn
Sep 30, 2021 23.44 Mn
API Access

Sarepta Therapeutics Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=SRPT&period=max&api_key=YOUR_API_KEY